Mouse hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity
James Brett Case(Washington University in St. Louis), Mark R. Denison(Bipar), Nicole R. Sexton(Blood Systems Research Institute), Xiaotao Lu(Vanderbilt University Medical Center), Kevin W. Graepel(National Institutes of Health), Everett Clinton Smith(Sewanee: The University of the South), Ruth Elliott(University of Pennsylvania), Yize Li(Northeast Agricultural University), Susan R. Weiss(Philadelphia University)
Cited by 4
Related Papers
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
|Science Translational Medicine|2020|1.2k